Hologic, Inc. (BMV:HOLX)

Hologic Statistics

Total Valuation

Hologic has a market cap or net worth of MXN 304.05 billion. The enterprise value is 311.70 billion.

Market Cap	304.05B
Enterprise Value	311.70B

Important Dates

The next estimated earnings date is Friday, January 30, 2026.

Earnings Date	Jan 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	222.42M
Shares Outstanding	n/a
Shares Change (YoY)	-4.20%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	1.57%
Owned by Institutions (%)	99.00%
Float	219.22M

Valuation Ratios

The trailing PE ratio is 29.28 and the forward PE ratio is 16.37.

PE Ratio	29.28
Forward PE	16.37
PS Ratio	4.04
PB Ratio	3.28
P/TBV Ratio	20.25
P/FCF Ratio	18.00
P/OCF Ratio	15.67
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.46, with an EV/FCF ratio of 18.46.

EV / Earnings	30.02
EV / Sales	4.18
EV / EBITDA	12.46
EV / EBIT	16.28
EV / FCF	18.46

Financial Position

The company has a current ratio of 3.75, with a Debt / Equity ratio of 0.52.

Current Ratio	3.75
Quick Ratio	2.87
Debt / Equity	0.52
Debt / EBITDA	1.90
Debt / FCF	2.85
Interest Coverage	9.06

Financial Efficiency

Return on equity (ROE) is 11.12% and return on invested capital (ROIC) is 8.58%.

Return on Equity (ROE)	11.12%
Return on Assets (ROA)	7.30%
Return on Invested Capital (ROIC)	8.58%
Return on Capital Employed (ROCE)	13.20%
Revenue Per Employee	10.65M
Profits Per Employee	1.47M
Employee Count	7,070
Asset Turnover	0.45
Inventory Turnover	2.36

Taxes

In the past 12 months, Hologic has paid 2.12 billion in taxes.

Income Tax	2.12B
Effective Tax Rate	16.96%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	13

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.20

Income Statement

In the last 12 months, Hologic had revenue of MXN 75.26 billion and earned 10.38 billion in profits. Earnings per share was 45.70.

Revenue	75.26B
Gross Profit	45.77B
Operating Income	19.48B
Pretax Income	12.50B
Net Income	10.38B
EBITDA	24.80B
EBIT	19.48B
Earnings Per Share (EPS)	45.70

Balance Sheet

The company has 40.49 billion in cash and 48.21 billion in debt, giving a net cash position of -7.73 billion.

Cash & Cash Equivalents	40.49B
Total Debt	48.21B
Net Cash	-7.73B
Net Cash Per Share	n/a
Equity (Book Value)	92.65B
Book Value Per Share	416.30
Working Capital	49.39B

Cash Flow

In the last 12 months, operating cash flow was 19.40 billion and capital expenditures -2.51 billion, giving a free cash flow of 16.89 billion.

Operating Cash Flow	19.40B
Capital Expenditures	-2.51B
Free Cash Flow	16.89B
FCF Per Share	n/a

Margins

Gross margin is 60.82%, with operating and profit margins of 25.88% and 13.80%.

Gross Margin	60.82%
Operating Margin	25.88%
Pretax Margin	16.61%
Profit Margin	13.80%
EBITDA Margin	32.95%
EBIT Margin	25.88%
FCF Margin	22.44%

Dividends & Yields

Hologic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.20%
Shareholder Yield	4.20%
Earnings Yield	3.42%
FCF Yield	5.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Hologic has an Altman Z-Score of 4.05 and a Piotroski F-Score of 7.

Altman Z-Score	4.05
Piotroski F-Score	7